
Ethris and Lonza Partner to Advance Spray-Dried mRNA Vaccines Targeting Respiratory Illnesses
Ethris and Lonza Partner to Advance Spray-Dried mRNA Vaccines Targeting Respiratory Illnesses In a major step toward transforming the landscape of vaccine development and delivery, Ethris, a clinical-stage biotechnology company leading innovation in RNA therapeutics and vaccines, has announced a…